Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995-2009
- PMID: 23488511
- PMCID: PMC3670653
- DOI: 10.2105/AJPH.2012.301049
Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995-2009
Abstract
Objectives: We examined the association between the expansion of methadone and buprenorphine treatment and the prevalence of heroin overdose deaths in Baltimore, Maryland from 1995 to 2009.
Methods: We conducted a longitudinal time series analysis of archival data using linear regression with the Newey-West method to correct SEs for heteroscedasticity and autocorrelation, adjusting for average heroin purity.
Results: Overdose deaths attributed to heroin ranged from a high of 312 in 1999 to a low of 106 in 2008. While mean heroin purity rose sharply (1995-1999), the increasing number of patients treated with methadone was not associated with a change in the number of overdose deaths, but starting in 2000 expansion of opioid agonist treatment was associated with a decline in overdose deaths. Adjusting for heroin purity and the number of methadone patients, there was a statistically significant inverse relationship between heroin overdose deaths and patients treated with buprenorphine (P = .002).
Conclusions: Increased access to opioid agonist treatment was associated with a reduction in heroin overdose deaths. Implementing policies that support evidence-based medication treatment of opiate dependence may decrease heroin overdose deaths.
Figures
Comment in
-
Schwartz et al. respond.Am J Public Health. 2013 Aug;103(8):e2-3. doi: 10.2105/AJPH.2013.301428. Epub 2013 Jun 13. Am J Public Health. 2013. PMID: 23763406 Free PMC article. No abstract available.
-
Efforts to reduce overdose deaths.Am J Public Health. 2013 Aug;103(8):e1-2. doi: 10.2105/AJPH.2013.301410. Epub 2013 Jun 13. Am J Public Health. 2013. PMID: 23763429 Free PMC article. No abstract available.
Similar articles
-
Efforts to reduce overdose deaths.Am J Public Health. 2013 Aug;103(8):e1-2. doi: 10.2105/AJPH.2013.301410. Epub 2013 Jun 13. Am J Public Health. 2013. PMID: 23763429 Free PMC article. No abstract available.
-
Schwartz et al. respond.Am J Public Health. 2013 Aug;103(8):e2-3. doi: 10.2105/AJPH.2013.301428. Epub 2013 Jun 13. Am J Public Health. 2013. PMID: 23763406 Free PMC article. No abstract available.
-
Opioid agonist treatment and fatal overdose risk in a state-wide US population receiving opioid use disorder services.Addiction. 2020 Sep;115(9):1683-1694. doi: 10.1111/add.14991. Epub 2020 Feb 24. Addiction. 2020. PMID: 32096302 Free PMC article.
-
Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.BMJ. 2017 Apr 26;357:j1550. doi: 10.1136/bmj.j1550. BMJ. 2017. PMID: 28446428 Free PMC article. Review.
-
Pharmacologic Treatment of Opioid Use Disorder: a Review of Pharmacotherapy, Adjuncts, and Toxicity.J Med Toxicol. 2018 Dec;14(4):306-322. doi: 10.1007/s13181-018-0685-1. Epub 2018 Oct 30. J Med Toxicol. 2018. PMID: 30377951 Free PMC article. Review.
Cited by
-
Patient experiences of buprenorphine dispensing from a mobile medical unit.Addict Sci Clin Pract. 2024 Jul 18;19(1):53. doi: 10.1186/s13722-024-00484-4. Addict Sci Clin Pract. 2024. PMID: 39026326 Free PMC article.
-
Series of (([1,1'-Biphenyl]-2-yl)methyl)sulfinylalkyl Alicyclic Amines as Novel and High Affinity Atypical Dopamine Transporter Inhibitors with Reduced hERG Activity.ACS Pharmacol Transl Sci. 2024 Jan 5;7(2):515-532. doi: 10.1021/acsptsci.3c00322. eCollection 2024 Feb 9. ACS Pharmacol Transl Sci. 2024. PMID: 38357284
-
Patient and Community Factors Affecting Treatment Access for Opioid Use Disorder.Obstet Gynecol. 2023 Aug 1;142(2):339-349. doi: 10.1097/AOG.0000000000005227. Epub 2023 Jul 5. Obstet Gynecol. 2023. PMID: 37473410 Free PMC article.
-
The impact of the implementation of medication for opioid use disorder and COVID-19 in a statewide correctional system on treatment engagement, postrelease continuation of care, and overdose.J Subst Use Addict Treat. 2023 Sep;152:209103. doi: 10.1016/j.josat.2023.209103. Epub 2023 Jun 11. J Subst Use Addict Treat. 2023. PMID: 37311520 Free PMC article.
-
Evaluation of the New England Office Based Addiction Treatment ECHO: A Tool for Strengthening the Addiction Workforce.Subst Abus. 2023 Jul;44(3):164-176. doi: 10.1177/08897077231179601. Epub 2023 Jun 7. Subst Abus. 2023. PMID: 37287240 Free PMC article.
References
-
- Hickman M, Carrivick S, Paterson Set al.London audit of drug-related overdose deaths: characteristics and typology, and implications for prevention and monitoring. Addiction. 2007;102(2):317–323 - PubMed
-
- Preti A, Miotto P, De Coppi M. Deaths by unintentional illicit drug overdose in Italy, 1984–2000. Drug Alcohol Depend. 2002;66(3):275–282 - PubMed
-
- World Health Organization Substitution Maintenance Therapy in the Management of Opioid Dependence and HIV/AIDS Prevention. Vienna: United Nations Office on Drugs and Crime; 2004
-
- Darke S, Duflou J, Torok M. A reduction in blood morphine concentrations amongst heroin overdose fatalities associated with a sustained reduction in street heroin purity. Forensic Sci Int. 2010;198(1–3):118–120 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical